Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors

Clinical trial NCT07589205 · RECRUITING

Trial details

NCT number: NCT07589205
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Colorectal Cancer Non-small Cell Lung Cancer Pancreatic Ductal Adenocarcinoma Head and Neck Squamous Cell Carcinoma

Start date: 2026-03-31
Primary completion: 2027-06-30
Enrollment: 493

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.